Gilead Sciences, Inc.
Imidazopyrimidine Derivatives
Last updated:
Abstract:
The present disclosure provides a compound of Formula (I): ##STR00001## or a pharmaceutically acceptable salt thereof as described herein. The present disclosure also provides pharmaceutical compositions comprising a compound of Formula I, processes for preparing compounds of Formula I, therapeutic methods for treating cancers.
Status:
Application
Type:
Utility
Filling date:
8 Oct 2021
Issue date:
4 Aug 2022